Back to Journals » OncoTargets and Therapy » Volume 11

Clinical benefit from afatinib in an advanced squamous cell lung carcinoma patient harboring HER2 S310Y mutation: a case report

Total article views   HTML views PDF downloads Totals
8,903 Dovepress* 7,405+ 863 8,268
PubMed Central* 1,498 345 1,843
Totals 8,903 1,208 10,111
*Since 5 December 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed Central and Google Scholar